Product Catalog [{"id":"608","name":"Zaltrap","price":701.97,"sku":"Zaltrap (aflibercept)","brand":"Sanofi - Aventis Groupe","position":1,"category":"Medicines\/Oncology\/Colorectal Cancer"},{"id":"594","name":"Fruzaqla","price":10736.06,"sku":"Fruzaqla (fruquintinib)","brand":"Takeda Pharma A\/S","position":2,"category":"Medicines\/Oncology\/Colorectal Cancer"},{"id":"527","name":"Vegzelma ","price":769.57,"sku":"Vegzelma (bevacizumab-adcd)","brand":"Celltrion Healthcare Hungary Kft","position":3,"category":"Medicines\/Oncology\/Colorectal Cancer"},{"id":"169","name":"Braftovi","price":901.88,"sku":"Braftovi (encorafenib)","brand":" Pierre Fabre Medicament","position":4,"category":"Medicines\/Oncology\/Colorectal Cancer"},{"id":"148","name":"Xeloda","price":1,"sku":"Xeloda (capecitabine)","brand":"Genentech","position":5,"category":"Medicines\/Oncology\/Colorectal Cancer"},{"id":"64","name":"Cyramza","price":640.06,"sku":"Cyramza (ramucirumab)","brand":"Lilly","position":6,"category":"Medicines\/Oncology\/Colorectal Cancer"},{"id":"35","name":"Keytruda","price":4225.5,"sku":"Keytruda (pembrolizumab)","brand":"Merck Sharp ","position":7,"category":"Medicines\/Oncology\/Colorectal Cancer"},{"id":"32","name":"Lonsurf","price":810,"sku":"Lonsurf (trifluridine\/tipiracil)","brand":"Les Laboratoires Servier","position":8,"category":"Medicines\/Oncology\/Colorectal Cancer"},{"id":"21","name":"Opdivo","price":867.24,"sku":"Opdivo (nivolumab)","brand":"Bristol-Myers Squibb Pharma EEIG","position":9,"category":"Medicines\/Oncology\/Colorectal Cancer"}]
Destek ekibimizi arayın: +31 20 8084 414
Google Yorumları
4.8
Navigasyonu Aç / Kapat
Arama
Gelişmiş Arama
Web sitemizin çeviri hataları içerebilecek otomatik olarak çevrilmiş bir versiyonunu okumaktasınız.
Change to English
Menü
Hesap

Kolorektal Kanser erişim seçenekleri

Globally, colorectal cancer is the third most common type of cancer making up about 10% of all cancer cases. In 2012 there were 1.4 million new cases and 694,000 deaths from colorectal cancer. The 5-year survival rates in the United States are around 65%. Colorectal cancer typically starts with a benign tumour. Colorectal cancer typically starts with a benign tumour, often in the form of a polyp, which over time becomes cancerous. Treatment options are depending on the stage of the disease, overall health and preferences of the patient. Standard treatments include surgery, chemotherapy, radiotherapy or a combination.
  1. Opdivo
    Opdivo Nivolumab)
    Ürotelyal Karsinom, Kolorektal Kanser, Baş ve Boyun Kanseri, Böbrek Kanseri, Karaciğer Kanseri, Akciğer Kanseri, Lenfoma, Cilt Kanseri
    € 867.24
  2. Lonsurf
    Lonsurf trifluridine/tipiracil)
    Kolorektal Kanser
    € 810.00
  3. Cyramza
    Cyramza ramucirumab)
    Kolorektal Kanser, Mide Kanseri, Akciğer Kanseri
    € 640.06
  4. Xeloda
    Xeloda
    Price available on request
  5. Braftovi
    Braftovi encorafenib)
    Kolorektal Kanser, Cilt Kanseri
    € 901.88
  6. Vegzelma
    Vegzelma (bevacizumab-adcd)
    Kolorektal Kanser, Jinekolojik Kanser, Böbrek Kanseri, Karaciğer Kanseri, Akciğer Kanseri
    € 769.57
  7. Fruzaqla
    Fruzaqla (fruquintinib)
    Kolorektal Kanser
    € 10,736.06
  8. Zaltrap
    Zaltrap (aflibercept)
    Kolorektal Kanser
    € 701.97
  9. Keytruda
    Keytruda pembrolizumab)
    Ürotelyal Karsinom, Meme Kanseri, Kolorektal Kanser, Mide Kanseri, Baş ve Boyun Kanseri, Böbrek Kanseri, Akciğer Kanseri, Lenfoma, Cilt Kanseri
    € 4,225.50
Olarak görüntüle Izgara Liste

9 Madde

Azalan Yönü Ayarla
Kolorektal Kanserde en son tedaviler hakkında daha fazla bilgi edinin
Hastalık alanlarını keşfedin
NZ Yeni Zelanda 0